This dissertation explores the potential of wearable devices to revolutionize pharmacovigilance by enabling real-time monitoring and detection of adverse drug reactions (ADRs). A utilitarian approach is used, emphasizing the practical application of technology to enhance patient safety and drug development. The research employs a mixed-methods approach, combining quantitative surveys and qualitative responses. The surveys, distributed electronically across Ireland, assess consumer perceptions of wearable devices and pharmacovigilance practices. Key findings highlight the potential of wearables to improve ADR detection. However, challenges such as data security, privacy concerns, and user engagement need to be addressed. The research concludes by recommending strategies for responsible and effective implementation of wearable technology in pharmacovigilance practices, including establishing robust data security measures, obtaining informed consent from patients, and developing userfriendly wearable devices. The study contributes to the advancement of patient safety and drug development by exploring the potential of wearable technology in pharmacovigilance. By implementing the recommendations outlined in this study, healthcare professionals can leverage this technology to improve patient outcomes and medication safety. A survey was conducted to assess patient attitudes and understanding of wearable technology in Ireland. The results revealed that a significant portion of the population (98.01%) uses smartphones daily and expresses interest in new technologies (99%). Smartwatches (77.22%) and activity trackers (29.70%) emerged as the most popular wearable devices. While a substantial number of respondents already use wearables (58.41%), ethical considerations and data privacy concerns were also evident. The analysis suggests that wearable devices, particularly smart clothing or accessories, hold promise for detecting ADRs due to their ability to track a wider range of physiological data points. However, concerns regarding data accuracy, security, and fairness in access necessitate the development of robust regulations and ethical guidelines. Overall, the findings indicate that wearable devices have the potential to become valuable tools in pharmacovigilance, but further research and development are crucial to address ethical concerns and ensure responsible data practices.